>A key reason for China's low-cost position, as the media are belatedly letting us know, is the absence of regulation on product quality, pollution, worker safety, etc. How does this work in pharma R&D, one of the most heavily regulated activities on earth? Do they plan on bribing the FDA to look the other way?<
I think you answered your own question: pharma is one of the most regulated activities on Earth.
The active pharmaceutical ingredients for most drugs sold in the U.S. (and everywhere else) have long been produced in the Third World because that’s where costs are lowest. Regards, Dew
Market Data 
Markets 
AI
